Skip to Content

JSP 544 (Digoxin 125 mcg (0.125 mg))

Pill imprint JSP 544 has been identified as Digoxin 125 mcg (0.125 mg).

Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Digoxin 125 mcg (0.125 mg) JSP 544
Digoxin 125 mcg (0.125 mg) JSP 544  Front
Digoxin 125 mcg (0.125 mg) JSP 544  Back
JSP 544
125 mcg (0.125 mg)
Prescription only
Drug Class:
Group V antiarrhythmics
Inotropic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Lannett Company, Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
aluminum oxide
lactose anhydrous
magnesium stearate
microcrystalline cellulose
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0989 Amerisource Health Services
66336-0374 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.